DMBT1 and Its Role in Neonatal Respiratory Distress Syndrome
Author Information
Author(s): Hanna Müller, Caroline End, Marcus Renner, Burkhard M Helmke, Nikolaus Gassler, Christel Weiss, Dominik Hartl, Matthias Griese, Mathias Hafner, Annemarie Poustka, Jan Mollenhauer, Johannes Poeschl
Primary Institution: University of Heidelberg
Hypothesis
Pulmonary DMBT1 could contribute to respiratory distress syndrome in neonates by modulating surfactant function.
Conclusion
DMBT1 increases lung surface tension in vitro, which may hinder surfactant supplementation in respiratory distress syndrome.
Supporting Evidence
- DMBT1 was localized in hyaline membranes during respiratory distress syndrome.
- In vitro addition of DMBT1 increased surface tension in a dose-dependent manner.
- Calcium addition reverted the DMBT1-mediated effect on surfactant surface tension.
Takeaway
DMBT1 is a protein that can make it harder for babies' lungs to work properly by increasing surface tension, which is not good for their breathing.
Methodology
DMBT1 expression was studied using immunohistochemistry and mRNA in situ hybridization in post-mortem lungs of neonates, and its effect on surfactant was measured using a capillary surfactometer.
Potential Biases
Potential bias in sample selection and the interpretation of immunohistochemical results.
Limitations
The study is limited by the small sample size and the inability to determine the exact in vivo effects of DMBT1 on surfactant function.
Participant Demographics
The study included 5 preterm and 2 full-term neonates with respiratory distress syndrome.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website